Jeffrey B. Brown - Oct 14, 2024 Form 4 Insider Report for Axil Brands, Inc. (AXIL)

Role
CFO, COO, Director
Signature
/s/ Jeffrey B. Brown
Stock symbol
AXIL
Transactions as of
Oct 14, 2024
Transactions value $
$0
Form type
4
Date filed
10/15/2024, 04:15 PM
Previous filing
Feb 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AXIL Common Stock 15.1K Oct 14, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXIL Stock Option (right to buy) Award $0 +250K $0.00 250K Oct 14, 2024 Common Stock 250K $4.01 Direct F2
holding AXIL Stock Option (right to buy) 110K Oct 14, 2024 Common Stock 110K $1.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully exercisable.
F2 Options vest in 48 equal monthly installments, beginning on October 14, 2024, the date of grant, subject to continued employment through the vesting date.

Remarks:

On January 16, 2024, the Issuer effected a reverse stock split of the Issuer's common stock at a ratio of 1-for-20 (the "Reverse Stock Split"). As a result of the Reverse Stock Split, the shares of common stock, and the exercise price and shares of common stock underlying outstanding equity awards, have been adjusted accordingly, as compared to amounts previously reported by the Reporting Person. Effective February 14, 2024, the Issuer changed its legal name from Reviv3 Procare Company to AXIL Brands, Inc.